Biocon lands FDA approval for another Stelara biosimilar

Bio­con Bi­o­log­ics scored an FDA ap­proval for its Ste­lara biosim­i­lar, mar­ket­ed as Yesin­tek, the com­pa­ny an­nounced Mon­day.

Bio­con en­tered in­to a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.